Non Small Cell Lung Cancer — Patent Landscape
7
Approved drugs
87
Active US patents
44/100
Avg vulnerability
—
Annual revenue covered
Originators in Non Small Cell Lung Cancer
Pfizer
23 patents
Sanofi
18 patents
Accord Hlthcare
15 patents
Novartis
13 patents
Takeda
12 patents
Rigel Pharms
6 patents
Cliff calendar — next 15 years
9
27
2
28
13
29
4
30
6
31
5
32
21
33
5
34
3
35
11
36
1
37
2
38
4
39
Approved drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Taxotere
Docetaxel
|
Sanofi | 18 | 59 | — | 2031-08-07 |
|
Xalkori
crizotinib
|
Pfizer | 15 | 40 | — | 2027-05-12 |
|
Gemzar
Gemcitabine Hydrochloride
|
Accord Hlthcare | 15 | 48 | — | 2030-06-28 |
|
Zykadia
ceritinib
|
Novartis | 13 | 34 | — | 2027-11-20 |
|
Alunbrig
brigatinib
|
Takeda | 12 | 51 | — | 2029-05-21 |
|
Lorbrena
lorlatinib
|
Pfizer | 8 | 30 | — | 2033-03-05 |
|
Gavreto
PRALSETINIB
|
Rigel Pharms | 6 | 45 | — | 2036-11-01 |
Most attackable patents
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 7825137 | Xalkori | method of use | 88 | 2027-05-12 |
| 7825137 | Xalkori | method of use | 88 | 2027-05-12 |
| 7825137 | Xalkori | method of use | 88 | 2027-05-12 |
| 7825137 | Xalkori | method of use | 85 | 2027-05-12 |
| 7825137 | Xalkori | method of use | 85 | 2027-05-12 |
| 8377921 | Zykadia | method of use | 80 | 2027-11-20 |
| 8377921 | Zykadia | method of use | 75 | 2027-11-20 |
| 11419842 | Taxotere | method of use | 75 | 2036-05-16 |
| 12090134 | Taxotere | method of use | 75 | 2036-05-16 |
| 12357630 | Zykadia | method of use | 75 | 2037-12-13 |
Strongest defences
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 12448366 | Gavreto | composition of matter | 0 | 2042-07-07 |
| 8680111 | Lorbrena | composition of matter | 4 | 2033-03-05 |
| 8680111 | Lorbrena | composition of matter | 4 | 2033-03-05 |
| 9309229 | Zykadia | composition of matter | 10 | 2032-01-18 |
| 9309229 | Zykadia | composition of matter | 10 | 2032-01-18 |
| 9012462 | Alunbrig | composition of matter | 10 | 2031-04-28 |
| 9012462 | Alunbrig | composition of matter | 10 | 2031-04-28 |
| 9012462 | Alunbrig | composition of matter | 10 | 2031-04-28 |
| 8039479 | Zykadia | composition of matter | 10 | 2030-06-29 |
| 11299500 | Lorbrena | composition of matter | 12 | 2038-10-04 |
Related
- Non Small Cell Lung Cancer — full disease profile
- AI Patent Landscape Report — type "non small cell lung cancer" for an AI exec memo
- Company Patent Rankings
- Biosimilar Opportunity Scanner